PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-8.74%
Negative revenue growth while NXPI stands at 5.05%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-1.10%
Negative gross profit growth while NXPI is at 9.00%. Joel Greenblatt would examine cost competitiveness or demand decline.
3.79%
EBIT growth below 50% of NXPI's 685.71%. Michael Burry would suspect deeper competitive or cost structure issues.
8.77%
Operating income growth under 50% of NXPI's 685.71%. Michael Burry would be concerned about deeper cost or sales issues.
-11.07%
Negative net income growth while NXPI stands at 86.81%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-11.54%
Negative EPS growth while NXPI is at 86.92%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-15.38%
Negative diluted EPS growth while NXPI is at 86.92%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
0.62%
Share count expansion well above NXPI's 0.54%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
1.04%
Diluted share count expanding well above NXPI's 0.54%. Michael Burry would fear significant dilution to existing owners' stakes.
0.42%
Dividend growth of 0.42% while NXPI is flat. Bruce Berkowitz would see if this can become a bigger advantage long term.
-53.76%
Negative OCF growth while NXPI is at 385.29%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-57.70%
Negative FCF growth while NXPI is at 163.75%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
183.96%
10Y revenue/share CAGR above 1.5x NXPI's 20.93%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
23.39%
5Y revenue/share CAGR 1.25-1.5x NXPI's 20.93%. Bruce Berkowitz would verify if cost efficiency or pricing power supports this advantage.
66.90%
3Y revenue/share CAGR above 1.5x NXPI's 20.93%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
152.15%
10Y OCF/share CAGR 1.25-1.5x NXPI's 122.88%. Bruce Berkowitz would confirm if the firm's long-term capital allocation yields better cash returns.
2.25%
Below 50% of NXPI's 122.88%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
99.54%
3Y OCF/share CAGR at 75-90% of NXPI's 122.88%. Bill Ackman would press for improvements in margin or overhead to catch up.
1259.23%
Net income/share CAGR above 1.5x NXPI's 96.40% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
-35.21%
Negative 5Y net income/share CAGR while NXPI is 96.40%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
1638.85%
3Y net income/share CAGR above 1.5x NXPI's 96.40%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
55.33%
Equity/share CAGR of 55.33% while NXPI is zero. Bruce Berkowitz might see a slight advantage that can compound significantly over 10 years.
23.79%
Equity/share CAGR of 23.79% while NXPI is zero. Bruce Berkowitz might see a minor advantage that could compound if the firm maintains positive net worth growth.
34.09%
Equity/share CAGR of 34.09% while NXPI is zero. Bruce Berkowitz sees if minor gains can snowball into a bigger lead soon.
776.07%
Dividend/share CAGR of 776.07% while NXPI is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
324.16%
Dividend/share CAGR of 324.16% while NXPI is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
54.27%
3Y dividend/share CAGR of 54.27% while NXPI is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
-4.34%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
3.64%
Inventory growth well above NXPI's 0.16%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
-2.38%
Negative asset growth while NXPI invests at 1.06%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
0.47%
Positive BV/share change while NXPI is negative. John Neff sees a clear edge over a competitor losing equity.
-5.49%
We’re deleveraging while NXPI stands at 0.79%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
7.38%
We increase R&D while NXPI cuts. John Neff sees a short-term profit drag but a potential lead in future innovations.
4.05%
We expand SG&A while NXPI cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.